Calumet Specialty Products Partners LP (CLMT) shares are soaring 5.05% in intraday trading on Friday, despite reporting a wider-than-expected loss for the first quarter of 2025. The stock's rally appears to be driven by better-than-anticipated sales figures and progress in the company's cost reduction initiatives.
The specialty hydrocarbon producer reported Q1 sales of $993.9 million, significantly surpassing analysts' expectations of $891.4 million. Additionally, Calumet's adjusted EBITDA came in at $56.3 million, outperforming the consensus estimate of $43.5 million. These positive metrics seem to have overshadowed the company's reported loss of $2.59 per share, which was considerably wider than the expected loss of $0.57 per share.
Investors appear to be particularly encouraged by Calumet's progress in its cost reduction plan. The company announced that it is on track with a $22 million year-over-year reduction in operating costs, demonstrating management's commitment to improving operational efficiency. This focus on cost management, combined with the strong top-line performance, seems to have bolstered investor confidence in Calumet's long-term prospects, driving the stock's impressive intraday surge despite the challenging bottom-line results.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.